BIOMAT Database Logo BIOMAT Database Logo

[Dimexide in the overall treatment of radiation pneumonitis in lung cancer patients]. 1980

Iu Kh Sarkisian, and I Iu Kir'ianov, and L A Zhakova, and V A Silaeva, and V I Il'in

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D011832 Radiation Injuries Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES. Radiation Sickness,Radiation Syndrome,Injuries, Radiation,Injury, Radiation,Radiation Injury,Radiation Sicknesses,Radiation Syndromes,Sickness, Radiation,Sicknesses, Radiation,Syndrome, Radiation,Syndromes, Radiation
D004121 Dimethyl Sulfoxide A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation. DMSO,Dimethyl Sulphoxide,Dimethylsulfoxide,Dimethylsulphinyl,Dimethylsulphoxide,Dimexide,Rheumabene,Rimso,Rimso 100,Rimso-50,Sclerosol,Sulfinylbis(methane),Rimso 50,Rimso50,Sulfoxide, Dimethyl,Sulphoxide, Dimethyl
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Iu Kh Sarkisian, and I Iu Kir'ianov, and L A Zhakova, and V A Silaeva, and V I Il'in
[Overall treatment of erysipelas using dimexide].
January 1981, Klinicheskaia khirurgiia,
Iu Kh Sarkisian, and I Iu Kir'ianov, and L A Zhakova, and V A Silaeva, and V I Il'in
Challenges in defining radiation pneumonitis in patients with lung cancer.
July 2005, International journal of radiation oncology, biology, physics,
Iu Kh Sarkisian, and I Iu Kir'ianov, and L A Zhakova, and V A Silaeva, and V I Il'in
[SPECT lung perfusion scans in predicting radiation pneumonitis in lung cancer patients].
February 2006, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Iu Kh Sarkisian, and I Iu Kir'ianov, and L A Zhakova, and V A Silaeva, and V I Il'in
Challenges scoring radiation pneumonitis in patients irradiated for lung cancer.
June 2012, Lung cancer (Amsterdam, Netherlands),
Iu Kh Sarkisian, and I Iu Kir'ianov, and L A Zhakova, and V A Silaeva, and V I Il'in
Analysis of radiation pneumonitis and radiation-induced lung fibrosis in breast cancer patients after breast conservation treatment.
January 1999, Oncology reports,
Iu Kh Sarkisian, and I Iu Kir'ianov, and L A Zhakova, and V A Silaeva, and V I Il'in
Prediction of radiation pneumonitis in lung cancer patients: a systematic review.
December 2012, Journal of cancer research and clinical oncology,
Iu Kh Sarkisian, and I Iu Kir'ianov, and L A Zhakova, and V A Silaeva, and V I Il'in
[Therapeutic effectiveness of dimexide in the overall treatment of meningococcal infection].
July 1978, Vrachebnoe delo,
Iu Kh Sarkisian, and I Iu Kir'ianov, and L A Zhakova, and V A Silaeva, and V I Il'in
Clinical treatment of acute radiation pneumonitis caused by radiation therapy for lung cancer.
June 2024, Minerva gastroenterology,
Iu Kh Sarkisian, and I Iu Kir'ianov, and L A Zhakova, and V A Silaeva, and V I Il'in
Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.
June 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Iu Kh Sarkisian, and I Iu Kir'ianov, and L A Zhakova, and V A Silaeva, and V I Il'in
Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab.
July 2020, Cancer medicine,
Copied contents to your clipboard!